HLA-DMA antibody
Quick Overview for HLA-DMA antibody (ABIN1107564)
Target
See all HLA-DMA AntibodiesReactivity
Host
Clonality
Conjugate
Application
Clone
-
-
Specificity
- The antibody reacts with murine MHC class II glycoproteins. It recognizes a shared determinant on I-Ab, I-Ad, I-Aq, and I-Ed, I-Ek alloantigens, but it does not react with I-Af, I-Ak, I-As. This antibody can inhibit I-A-restricted T cell responses of the H-2b, H-2d, H-2q, H-2u but not H-2f, H-2k, H-2s haplotypes.
-
Cross-Reactivity (Details)
- Species reactivity (tested):Mouse
-
Purification
- Protein-G affinity chromatography
-
Purity
- > 95 % pure by SDS-PAGE
-
Immunogen
- Activated C57BL/6 mouse spleen cells
-
Isotype
- IgG2b
-
-
-
-
Application Notes
- Optimal working dilution should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Concentration
- 1.0 mg/mL
-
Buffer
- Azide free phosphate buffered saline (PBS), approx. pH 7.4, 0.2 μm filter sterilized
-
Preservative
- Azide free
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody at 2 - 8 °C up to one month or (in aliquots) at -20 °C for longer.
-
-
- HLA-DMA (Major Histocompatibility Complex, Class II, DM alpha (HLA-DMA))
-
Background
- MHC (major histocompatibility complex) class II molecules are transmembrane glycoproteins expressed on the surface of professional antigen-presenting cells, such as macrophages, dendritic cells and B cells. Before their exposition on the cell surface, the MHC class II molecules react with endocytosed exogenous antigens, which are then presented to the T cells. The antigen-binding grove between MHC class II alpha and beta chain is open at both ends and is 15-24 amino acid residues long.Synonyms: DM alpha chain, DMA, HLA class II histocompatibility antigen, MHC class II antigen DMA, RING6, Really interesting new gene 6 protein
-
Gene ID
- 3108
-
NCBI Accession
- NP_006111
-
UniProt
- P28067
-
Pathways
- Cancer Immune Checkpoints, Human Leukocyte Antigen (HLA) in Adaptive Immune Response
Target
-